• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Assessment of serum ADA and hsCRP level in psoriatic patients

    Dr.Deepika Agarwal, Dr.Bhawna Kapoor

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 1830-1834

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background:Psoriasis is a chronic, immune-mediated skin disease. The present study was
conducted to assess serum ADA and hsCRP level in psoriatic patients.
Materials & Methods:66 patients of Psoriasis of both genders were divided according to
PASI score <10 defined psoriasis asmild, between 10 and 20 as moderate, and >20 assevere.
Each group contains 22 patients. 25 healthy subjects were included as a control group. Serum
ADA and hsCRP levelwere measured in psoriatic patients.
Results: Control group had 10 males and 15 females, mild had 13 males and 9 females,
moderate had 12 males and 10 females and severe had 11 males and 11 females. ADA level
was 8.2 U/L in control group and 23.1 U/L in psoriasis patients. The mean hsCRP level in
control group was 9.0 ng/ml and 54.2 ng/ml in psoriasis group. The difference was significant
(P< 0.05).
Conclusion: Serum ADA and hsCRP had higher levels among psoriatic patients than healthy
controls.
Keywords:
    Serum ADA hsCRP Psoriasis
  • PDF (170 K)
  • XML
(2022). Assessment of serum ADA and hsCRP level in psoriatic patients. European Journal of Molecular & Clinical Medicine, 9(3), 1830-1834.
Dr.Deepika Agarwal, Dr.Bhawna Kapoor. "Assessment of serum ADA and hsCRP level in psoriatic patients". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 1830-1834.
(2022). 'Assessment of serum ADA and hsCRP level in psoriatic patients', European Journal of Molecular & Clinical Medicine, 9(3), pp. 1830-1834.
Assessment of serum ADA and hsCRP level in psoriatic patients. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 1830-1834.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 9
  • PDF Download: 26
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus